Pharmacokinetic Optimisation in the Treatment of Parkinson’s Disease Dag Nyholm Review Article 08 January 2013 Pages: 109 - 136
Fosamprenavir Mary Beth WireMark J. SheltonScott Studenberg Review Article 08 January 2013 Pages: 137 - 168
Pharmacokinetic Interaction between Levofloxacin and Ciclosporin or Tacrolimus in Kidney Transplant Recipients Stefano FedericoRosa CarranoVincenzo Basile Original Research Article 08 January 2013 Pages: 169 - 175
Role of Mechanistically-Based Pharmacokinetic/Pharmacodynamic Models in Drug Development Scott MarshallFiona MacintyreNiclas E. Jonsson Original Research Article 08 January 2013 Pages: 177 - 197
Pharmacokinetics of Darbepoetin Alfa after Intravenous or Subcutaneous Administration in Patients with Non-myeloid Malignancies Undergoing Chemotherapy Anne C. HeatheringtonChristian DittrichJohannes Schneller Original Research Article 08 January 2013 Pages: 199 - 211
Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals David J. BackAndrew OwenSaye H. Khoo Correspondence 08 January 2013 Pages: 213 - 214
The Authors’ Reply Alwin D. R. HuitemaJos H. Beijnen Correspondence 08 January 2013 Pages: 214 - 215